Skip to main content
4 March 2021
Last updated:
Monday 1 March 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Evernow Publishing Ltd Privacy Policy. Read more.

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Free featured article

Genmab gains traction

Friday 26 February 2021
Country

Denmark

Genmab A/S moved a step closer towards its goal of becoming a fully integrated biotech in 2020 following a licensing deal with AbbVie Inc which pushed revenue higher and put the Danish company on course to co-develop three bispecific antibody compounds. The agreement, concluded in June, delivered an upfront payment of $750 million, helping to deliver significantly higher revenue for the year.

Read more

Merck withdraws lung cancer indication for Keytruda

Monday 1 March 2021
Country

United States

Merck & Co Inc has voluntarily withdrawn the metastatic small cell lung cancer indication for Keytruda (pembrolizumab) following the results of a Phase 3 study which didn’t support the terms of its earlier accelerated approval from the US Food and Drug Administration. The FDA awards accelerated approvals to certain drugs, based on surrogate endpoints, but confirmation of clinical benefit needs to be verified in subsequent trials.

Read more

Oxular secures $37 million for retinal treatments

Monday 1 March 2021
Country

United Kingdom

UK-based Oxular Ltd has secured $37 million in venture finance to advance its lead product for diabetic macular edema (DME) into Phase 2 as well as support earlier stage ophthalmologic products. The venture capital firm Forbion led the financing, which included existing investors IP Group, NeoMed and V-Bio Ventures.

Read more

FDA clears third Covid-19 vaccine

Sunday 28 February 2021
Country

United States

Read more

Merck to acquire Pandion Therapeutics

Sunday 28 February 2021
Country

United States

Read more

DMD drug approved in US

Friday 26 February 2021
Country

United States

Read more

MitoRx Therapeutics readied for launch

Wednesday 24 February 2021
Country

United Kingdom

Read more

UCB and Microsoft to collaborate

Tuesday 23 February 2021
Country

Belgium

Read more

Targovax oncolytic virus continues to benefit

Tuesday 23 February 2021
Country

Norway

Read more

AZ withdraws Imfinzi indication

Monday 22 February 2021
Country

United Kingdom

Read more

A new chapter for argenx

Monday 22 February 2021
Country

Netherlands

Read more

Evox completes Series C financing

Monday 22 February 2021
Country

United Kingdom

Read more

Consolidation at Galapagos

Friday 19 February 2021
Country

Netherlands

Read more
Looking for more?

Visit our news section for more articles.

News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

What we need to know about SARS-CoV-2 variants

What we need to know about SARS-CoV-2 variants, By Peter Charlish

Latest MedNous Issue Highlights

February 2021 edition of MedNous

Gene Therapy
Interview with Purespring
Therapeutics

Coronavirus
What we need to know
about SARS-CoV-2 variants
By Peter Charlish

Epigenetics
The quest for personalised
medicines to treat CNS
disorders
By Carlos Buesa

Research Strategy
Taming food-induced
immune disorders
By Poul Sørensen

 

The latest MedNous journal. Subscribe to download.

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.